After Another Cadillac Tax Delay, Now What?
With the tax perhaps unlikely to ever take effect, should companies still factor it into their benefits planning and strategies?
How Might Trump Health-Care Order Affect Group Plans?
If companies were allowed to fund HRAs for the purpose of allowing workers to buy their own insurance, some companies might do it, research suggests.
Specialty Drug Costs to Soar Again in 2018
The rate of spending increase on high-tech pharmaceuticals will top 17% for a second consecutive year, a study says.
TrumpCare Could Cause Cost Shift To Employers, Experts Warn
Millions of newly uninsured could cause a spike in costs for health-care providers, who likely would pass the costs on to private payers.
Growth Rate for Health Costs Sank This Year
The average increase was only 2.4%, a historically low rate, according to Mercer data.
More Firms Have Positive View of Obamacare Ruling
29% said the decision would be good for them, compared with 17% who said it wouldn't.
Health Plan Enrollment Fears Prove Moot
New Affordable Care Act requirements to offer health benefits to more employees didn't budge the enrollment needle at all.
Costs Slow as Health Care Consumerism Grows
Annual hikes remain historically low for a second consecutive year, partly in response to corporate benefits strategies.